---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-005763"
form_type: "8-K"
ticker: "CMPX"
cik: "0001738021"
company_name: "Compass Therapeutics, Inc."
filed_at: "2022-08-19T23:59:59+00:00"
generated_at: "2026-06-23T22:34:24.270045+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Compass Therapeutics director Stephen Squinto resigns from board effective Aug 31

## Summary
- Stephen Squinto, Ph.D., notified Compass of his resignation from the Board and all committees, effective August 31, 2022.
- Resignation not due to any disagreement with the Company on operations, policies, or practices.
- Dr. Squinto had been a Board member since 2015, representing an early investor; he is leaving to pursue other professional endeavors.

## SEC filing metadata
- accession: 0001171843-22-005763
- form_type: 8-K
- ticker: CMPX
- cik: 0001738021
- company_name: Compass Therapeutics, Inc.
- filed_at: 2022-08-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1738021/000117184322005763/0001171843-22-005763-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1738021/000117184322005763/f8k_081922.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-005763
- JSON: https://secwatch.observer/filing/0001171843-22-005763.json
- Plain text: https://secwatch.observer/filing/0001171843-22-005763.txt

## Key facts
- Executive change
  Stephen Squinto resigned as Director at Compass Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 17, 2022, Stephen Squinto, Ph.D., a member of the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board and all committees thereof, effective August 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1738021/000117184322005763/0001171843-22-005763-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.